Loading…

Pathogenesis of diffuse large B cell lymphoma

Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormal...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2010-09, Vol.92 (2), p.219-230
Main Author: Chan, Wing (John) C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753
cites cdi_FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753
container_end_page 230
container_issue 2
container_start_page 219
container_title International journal of hematology
container_volume 92
creator Chan, Wing (John) C.
description Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities. The ability to correlate corresponding genetic and GEP data markedly facilitates the identification of target genes in regions with copy number abnormalities. Oncogenic pathways are often differentially activated in these different subtypes of DLBCL, suggesting that therapy should be targeted according to these differences. The tumor microenvironment plays a significant role in determining outcome and may be a novel target for therapy. The role of microRNA in lymphomagenesis is increasingly being recognized and mutation of key genes has been demonstrated to drive the activation of the NF-κB pathway and B cell receptor signaling. The pace of discovery will be even more rapid in the near future with the convergence of data from multiple complementary genome-wide studies and technological innovations including the rapid advance in the technology of high-throughput sequencing.
doi_str_mv 10.1007/s12185-010-0602-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754029352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2139332301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBdZBPEUnUk2m92jFr-goIfeQ5pN2i37UZPuof_elK0Kgqc55Jl33jyEXCLcIYC8D8gwFxQQKGTAKByRMeaZoFzK9JiMoWCCCokwImchrAFQQipPyYiByJnkckzoh96uuqVtbahC0rmkrJzrg01q7Zc2eUyMreuk3jWbVdfoc3LidB3sxWFOyPz5aT59pbP3l7fpw4yatBBbarhIAXVaLrLSuNyJ3OZWWwDBnBAZy6WV3BnHUshSzQ2yTLDMpBKlcVLwCbkdYje---xt2KqmCvsiurVdH5SM8azggkXy-g-57nrfxm4RQsQi_jdCOEDGdyF469TGV432O4Wg9iLVIFJFkWovUkHcuToE94vGlj8b3-YicHMAdDC6dl63pgq_HOcZSOSRYwMX4lO7tP634f_XvwBa04e2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>751119047</pqid></control><display><type>article</type><title>Pathogenesis of diffuse large B cell lymphoma</title><source>Springer Nature</source><creator>Chan, Wing (John) C.</creator><creatorcontrib>Chan, Wing (John) C.</creatorcontrib><description>Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities. The ability to correlate corresponding genetic and GEP data markedly facilitates the identification of target genes in regions with copy number abnormalities. Oncogenic pathways are often differentially activated in these different subtypes of DLBCL, suggesting that therapy should be targeted according to these differences. The tumor microenvironment plays a significant role in determining outcome and may be a novel target for therapy. The role of microRNA in lymphomagenesis is increasingly being recognized and mutation of key genes has been demonstrated to drive the activation of the NF-κB pathway and B cell receptor signaling. The pace of discovery will be even more rapid in the near future with the convergence of data from multiple complementary genome-wide studies and technological innovations including the rapid advance in the technology of high-throughput sequencing.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-010-0602-0</identifier><identifier>PMID: 20582737</identifier><language>eng</language><publisher>Japan: Springer Japan</publisher><subject>Biological and medical sciences ; Gene Dosage ; Gene Expression Profiling ; Hematologic and hematopoietic diseases ; Hematology ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, Large B-Cell, Diffuse - classification ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoma, Large B-Cell, Diffuse - etiology ; Lymphoma, Large B-Cell, Diffuse - genetics ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; MicroRNAs ; Oncology ; Progress in Hematology ; Signal Transduction ; Tumor Microenvironment</subject><ispartof>International journal of hematology, 2010-09, Vol.92 (2), p.219-230</ispartof><rights>The Japanese Society of Hematology 2010</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753</citedby><cites>FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23360713$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20582737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Wing (John) C.</creatorcontrib><title>Pathogenesis of diffuse large B cell lymphoma</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities. The ability to correlate corresponding genetic and GEP data markedly facilitates the identification of target genes in regions with copy number abnormalities. Oncogenic pathways are often differentially activated in these different subtypes of DLBCL, suggesting that therapy should be targeted according to these differences. The tumor microenvironment plays a significant role in determining outcome and may be a novel target for therapy. The role of microRNA in lymphomagenesis is increasingly being recognized and mutation of key genes has been demonstrated to drive the activation of the NF-κB pathway and B cell receptor signaling. The pace of discovery will be even more rapid in the near future with the convergence of data from multiple complementary genome-wide studies and technological innovations including the rapid advance in the technology of high-throughput sequencing.</description><subject>Biological and medical sciences</subject><subject>Gene Dosage</subject><subject>Gene Expression Profiling</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, Large B-Cell, Diffuse - classification</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - etiology</subject><subject>Lymphoma, Large B-Cell, Diffuse - genetics</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>MicroRNAs</subject><subject>Oncology</subject><subject>Progress in Hematology</subject><subject>Signal Transduction</subject><subject>Tumor Microenvironment</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMotlZ_gBdZBPEUnUk2m92jFr-goIfeQ5pN2i37UZPuof_elK0Kgqc55Jl33jyEXCLcIYC8D8gwFxQQKGTAKByRMeaZoFzK9JiMoWCCCokwImchrAFQQipPyYiByJnkckzoh96uuqVtbahC0rmkrJzrg01q7Zc2eUyMreuk3jWbVdfoc3LidB3sxWFOyPz5aT59pbP3l7fpw4yatBBbarhIAXVaLrLSuNyJ3OZWWwDBnBAZy6WV3BnHUshSzQ2yTLDMpBKlcVLwCbkdYje---xt2KqmCvsiurVdH5SM8azggkXy-g-57nrfxm4RQsQi_jdCOEDGdyF469TGV432O4Wg9iLVIFJFkWovUkHcuToE94vGlj8b3-YicHMAdDC6dl63pgq_HOcZSOSRYwMX4lO7tP634f_XvwBa04e2</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Chan, Wing (John) C.</creator><general>Springer Japan</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100901</creationdate><title>Pathogenesis of diffuse large B cell lymphoma</title><author>Chan, Wing (John) C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Gene Dosage</topic><topic>Gene Expression Profiling</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, Large B-Cell, Diffuse - classification</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - etiology</topic><topic>Lymphoma, Large B-Cell, Diffuse - genetics</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>MicroRNAs</topic><topic>Oncology</topic><topic>Progress in Hematology</topic><topic>Signal Transduction</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Wing (John) C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Wing (John) C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogenesis of diffuse large B cell lymphoma</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>92</volume><issue>2</issue><spage>219</spage><epage>230</epage><pages>219-230</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>Substantial additional insight has been obtained in the past decade regarding the pathogenesis of diffuse large B cell lymphoma (DLBCL). Distinct subtypes of DLBCL have been defined by gene expression profiling (GEP) and they differ not only in GE profiles but also in the pattern of genetic abnormalities. The ability to correlate corresponding genetic and GEP data markedly facilitates the identification of target genes in regions with copy number abnormalities. Oncogenic pathways are often differentially activated in these different subtypes of DLBCL, suggesting that therapy should be targeted according to these differences. The tumor microenvironment plays a significant role in determining outcome and may be a novel target for therapy. The role of microRNA in lymphomagenesis is increasingly being recognized and mutation of key genes has been demonstrated to drive the activation of the NF-κB pathway and B cell receptor signaling. The pace of discovery will be even more rapid in the near future with the convergence of data from multiple complementary genome-wide studies and technological innovations including the rapid advance in the technology of high-throughput sequencing.</abstract><cop>Japan</cop><pub>Springer Japan</pub><pmid>20582737</pmid><doi>10.1007/s12185-010-0602-0</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0925-5710
ispartof International journal of hematology, 2010-09, Vol.92 (2), p.219-230
issn 0925-5710
1865-3774
language eng
recordid cdi_proquest_miscellaneous_754029352
source Springer Nature
subjects Biological and medical sciences
Gene Dosage
Gene Expression Profiling
Hematologic and hematopoietic diseases
Hematology
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, Large B-Cell, Diffuse - classification
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - etiology
Lymphoma, Large B-Cell, Diffuse - genetics
Medical sciences
Medicine
Medicine & Public Health
MicroRNAs
Oncology
Progress in Hematology
Signal Transduction
Tumor Microenvironment
title Pathogenesis of diffuse large B cell lymphoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A31%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogenesis%20of%20diffuse%20large%20B%20cell%20lymphoma&rft.jtitle=International%20journal%20of%20hematology&rft.au=Chan,%20Wing%20(John)%20C.&rft.date=2010-09-01&rft.volume=92&rft.issue=2&rft.spage=219&rft.epage=230&rft.pages=219-230&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-010-0602-0&rft_dat=%3Cproquest_cross%3E2139332301%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c495t-c35401a4db6dcf8f58e8eae0052f556287e73fcf24064a3c126526c4717cf753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=751119047&rft_id=info:pmid/20582737&rfr_iscdi=true